Zydus Lifesciences gets USFDA nod for generic cancer treatment capsules

Zydus Lifesciences Ltd has received final approval from the USFDA for its generic version of the cancer treatment drug Cyclophosphamide capsules. The approval covers strengths of 25 mg and 50 mg.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/JzxXEOe
via IFTTT